We are live on ! Find out more
HCWB icon

HCW Biologics
HCWB

16 hedge funds and large institutions have $626K invested in HCW Biologics in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.01% → 0.01% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

16% less funds holding

Funds holding: 19 → 16 (-3)

20% less capital invested

Capital invested by funds: $784K → $626K (-$159K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
16
Holders Change
-3
Holders Change %
-15.79%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$7.36K
2
BlackRock
BlackRock
New York
+$954
3
UBS Group
UBS Group
Switzerland
+$273

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$15.6K
2
HF
HRT Financial
New York
-$11.4K
3
Citadel Advisors
Citadel Advisors
Florida
-$8.98K
4
PIM
Pullen Investment Management
Florida
-$5.72K
5
TRCT
Tower Research Capital (TRC)
New York
-$136
Name Holding Trade Value Shares
Change 		Change in
Stake
APP
1
Avantax Planning Partners
Iowa
$151K – – –
Geode Capital Management
2
Geode Capital Management
Massachusetts
$98.9K +$7.36K +54 +8%
HighTower Advisors
3
HighTower Advisors
Illinois
$98K – – –
CAM
4
Cresset Asset Management
Illinois
$71.2K – – –
BCM
5
Bridgeway Capital Management
Texas
$45.7K – – –
PIM
6
Pullen Investment Management
Florida
$40.5K -$5.72K -42 -12%
HF
7
HRT Financial
New York
$25K -$11.4K -84 -30%
BlackRock
8
BlackRock
New York
$23.9K +$954 +7 +4%
Vanguard Group
9
Vanguard Group
Pennsylvania
$20.3K – – –
AWM
10
AE Wealth Management
Kansas
$16.2K – – –
Two Sigma Investments
11
Two Sigma Investments
New York
$12.1K – – –
State Street
12
State Street
Massachusetts
$11.6K – – –
Northern Trust
13
Northern Trust
Illinois
$5.5K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$3.17K -$136 -1 -4%
UBS Group
15
UBS Group
Switzerland
$2.6K +$273 +2 +11%
Bank of America
16
Bank of America
North Carolina
$183 – – –
Jane Street
17
Jane Street
New York
– -$15.6K -101 Closed
Citadel Advisors
18
Citadel Advisors
Florida
– -$8.98K -58 Closed

HCWB Hedge Fund Activity: Q3 2024 in Review

16 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in HCW Biologics (HCWB) for Q3 2024, worth a combined $626K — down 20% from $784K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of HCWB and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Geode Capital Management, adding an estimated $7.36K. The largest seller was Jane Street, exiting entirely with an estimated $15.6K sold.

  • 16 institutional investors held HCW Biologics (HCWB) as of Q3 2024, down from 19 in Q2 2024.
  • Funds reported $626K of HCW Biologics stock for Q3 2024, down 20% quarter-over-quarter.
  • 0 funds opened new HCW Biologics positions in Q3 2024 and 3 closed out, a net change of -3 holders.
  • The largest HCW Biologics buyer in Q3 2024 was Geode Capital Management, an estimated $7.36K added.
  • The largest HCW Biologics seller in Q3 2024 was Jane Street, an estimated $15.6K sold.

Based on aggregated 13F filings for Q3 2024.